本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

10.91
-0.0800-0.73%
盘后10.910.00000.00%16:10 EDT
成交量:8.38万
成交额:90.86万
市值:3.74亿
市盈率:-10.34
高:11.02
开:10.93
低:10.36
收:10.99
52周最高:17.15
52周最低:9.85
股本:3,425.49万
流通股本:2,085.08万
量比:0.89
换手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-1.0553
每股收益(LYR):-1.0472
净资产收益率:-33.50%
总资产收益率:-22.40%
市净率:1.99
市盈率(LYR):-10.42

数据加载中...

2022/11/10

重要事件披露

8-K - Current report
2022/10/18

重要事件披露

8-K - Current report
2022/10/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

重要事件披露

8-K - Current report
2022/09/12

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/07

重要事件披露

8-K - Current report
2022/09/02

重要事件披露

8-K - Current report
2022/09/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/08/11

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/08/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/29

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/05/16

重要事件披露

8-K - Current report